Notice:
|
Suspension of shipments during Golden Week Holidays: From 30 April to 14 May, deadline 17 April.
|
|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
discarded
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
2981R-2 |
Symbol |
TpnC41C |
Full Name |
Troponin C at 41C |
CG No |
CG2981 |
Old CG No |
CG2981 |
Synonyms |
TnC, CG2981, DmTpnCIIIa, DmTpnC41C, TpnC IIIa, DmTnC1, unnamed, TPNC, TnC41C, TpnC41C |
Accession No (Link to NCBI) |
NM_078895.3 |
Inserted Chr. |
ll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
Map Viewer |
|
Reference
[Please submit your publication]
|
Fairchild MJ, Islam F, Tanentzapf G. Identification of genetic networks that act in the somatic cells of the testis to mediate the developmental program of spermatogenesis. PLoS Genet (2017) 13(9) e1007026
[
PubMed ID = 28957323
]
[
RRC reference
]
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Perkins AD, Lee MJ, Tanentzapf G. The systematic identification of cytoskeletal genes required for Drosophila melanogaster muscle maintenance. Sci Data (2014) 1 140002
[
PubMed ID = 25977760
]
[
RRC reference
]
Apidianakis Y, Mindrinos MN, Xiao W, Tegos GP, Papisov MI, Hamblin MR, Davis RW, Tompkins RG, Rahme LG. Involvement of skeletal muscle gene regulatory network in susceptibility to wound infection following trauma. PLoS One (2007) 2(12) e1356
[
PubMed ID = 18159239
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgGCGATGAATTGACTAAGGAGC |
Primer Seq. 3' |
aatctagaggtaccCCACCGGTCATTACTTCCATA |
Predicted Fragment Size |
451 |
IR fragment full Seq |
0001 GCGATGAATT GACTAAGGAG CAAACTGCAT TACTACGTAA TNCATTTAAT GCTTTTGCAC
0061 CCTGAAAAAA ATGGATATAT CAACACAGCT ATGGTGGGTA CGATACTTAG CATGTTGGGT
0121 CATCAACTTG ATGATGCAAC TCTTGCTGAC ATTATCGCTG AAGTCGATGA GGATGGTTCG
0181 GGCCAAATCG AATTTGAAGA ATTTACCACC TTGGCAGCCC GCTTCCTTGT GGAAGAGGAC
0241 GCTGAAGCTA TGATGGCTGA ATTGAAGGAA GCTTTCCGCC TTTACGACAA AGAAGGAAAT
0301 GGATATATAA CTACTGGTGT TCTTCGTGAA ATCCTGCGCG AACTAGACGA TAAATTGACA
0361 AATGACGACC TGGACATGAT GATTGAGGAA ATTGATTNCG ATGGATCGGG TACTGTTGAT
0421 TTTGATGAAT TTATGGAAGT AATGACCGGT GG |
in silico PCR Fragment |
0001 GCGATGAATT GACTAAGGAG CAAACTGCAT TACTACGTAA TGCATTTAAT GCTTTTG-AC
0061 CCTGAAAAAA ATGGATATAT CAACACAGCT ATGGTGGGTA CGATACTTAG CATGTTGGGT
0121 CATCAACTTG ATGATGCAAC TCTTGCTGAC ATTATCGCTG AAGTCGATGA GGATGGTTCG
0181 GGCCAAATCG AATTTGAAGA ATTTACCACC CTGGCAGCCC GCTTCCTTGT GGAAGAGGAC
0241 GCTGAAGCTA TGATGGCTGA ATTGAAGGAA GCTTTCCGCC TTTACGACAA AGAAGGAAAT
0301 GGATATATAA CTACTGGTGT TCTTCGTGAA ATCCTGCGCG AACTAGACGA TAAATTGACA
0361 AATGACGACC TGGACATGAT GATTGAGGAA ATTGATTCCG ATGGATCGGG TACTGTTGAT
0421 TTTGATGAAT TTATGGAAGT AATGACCGGT GG |
Assemble Data |
2981R-2.IR_full 1 GCGATGAATTGACTAAGGAGCAAACTGCATTACTACGTAATNCATTTAATGCTTTTGCAC 60
||||||||||||||||||||||||||||||||||||||||| ||||||||||||||| ||
2981R-2.in silico 1 GCGATGAATTGACTAAGGAGCAAACTGCATTACTACGTAATGCATTTAATGCTTTTG-AC 60
2981R-2.IR_full 61 CCTGAAAAAAATGGATATATCAACACAGCTATGGTGGGTACGATACTTAGCATGTTGGGT 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2981R-2.in silico 61 CCTGAAAAAAATGGATATATCAACACAGCTATGGTGGGTACGATACTTAGCATGTTGGGT 120
2981R-2.IR_full 121 CATCAACTTGATGATGCAACTCTTGCTGACATTATCGCTGAAGTCGATGAGGATGGTTCG 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2981R-2.in silico 121 CATCAACTTGATGATGCAACTCTTGCTGACATTATCGCTGAAGTCGATGAGGATGGTTCG 180
2981R-2.IR_full 181 GGCCAAATCGAATTTGAAGAATTTACCACCTTGGCAGCCCGCTTCCTTGTGGAAGAGGAC 240
|||||||||||||||||||||||||||||| |||||||||||||||||||||||||||||
2981R-2.in silico 181 GGCCAAATCGAATTTGAAGAATTTACCACCCTGGCAGCCCGCTTCCTTGTGGAAGAGGAC 240
2981R-2.IR_full 241 GCTGAAGCTATGATGGCTGAATTGAAGGAAGCTTTCCGCCTTTACGACAAAGAAGGAAAT 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2981R-2.in silico 241 GCTGAAGCTATGATGGCTGAATTGAAGGAAGCTTTCCGCCTTTACGACAAAGAAGGAAAT 300
2981R-2.IR_full 301 GGATATATAACTACTGGTGTTCTTCGTGAAATCCTGCGCGAACTAGACGATAAATTGACA 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2981R-2.in silico 301 GGATATATAACTACTGGTGTTCTTCGTGAAATCCTGCGCGAACTAGACGATAAATTGACA 360
2981R-2.IR_full 361 AATGACGACCTGGACATGATGATTGAGGAAATTGATTNCGATGGATCGGGTACTGTTGAT 420
||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||
2981R-2.in silico 361 AATGACGACCTGGACATGATGATTGAGGAAATTGATTCCGATGGATCGGGTACTGTTGAT 420
2981R-2.IR_full 421 TTTGATGAATTTATGGAAGTAATGACCGGTGG 452
||||||||||||||||||||||||||||||||
2981R-2.in silico 421 TTTGATGAATTTATGGAAGTAATGACCGGTGG 452
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
433 |
0 |
0 |
9 |
NM_078895.3 |
CG2981-RA (TpnC41C), mRNA |
0 |
0 |
14 |
17 |
17 |
NM_057620.4 |
CG9073-RA (TpnC47D), mRNA |
0 |
0 |
3 |
3 |
14 |
NM_132103.2 |
CG3973-RA (CG3973), mRNA |
0 |
0 |
2 |
4 |
7 |
NM_140875.2 |
CG9372-RA (CG9372), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_001042830.1 |
CG41474-RA (CG41474), mRNA |
0 |
0 |
2 |
3 |
9 |
NM_136864.2 |
CG13185-RA (CG13185), mRNA |
0 |
0 |
1 |
5 |
3 |
NM_079042.3 |
CG8961-RA (tef), mRNA |
0 |
0 |
1 |
3 |
5 |
NM_078691.2 |
CG12532-RA (Bap), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_167171.1 |
CG1871-RB, transcript variant B (e(r)), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_079923.2 |
CG1871-RA, transcript variant A (e(r)), mRNA |
0 |
0 |
1 |
2 |
14 |
NM_001032051.1 |
CG33715-RD, transcript variant D (Msp-300), mRNA |
0 |
0 |
1 |
2 |
8 |
NM_001032053.1 |
CG33715-RB, transcript variant B (Msp-300), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_142359.2 |
CG31256-RA (Brf), mRNA |
0 |
0 |
0 |
18 |
24 |
NM_136329.2 |
CG12408-RA (TpnC4), mRNA |
0 |
0 |
0 |
8 |
33 |
NM_079398.2 |
CG7930-RA, transcript variant A (TpnC73F), mRNA |
0 |
0 |
0 |
6 |
25 |
NM_168715.1 |
CG7930-RB, transcript variant B (TpnC73F), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_166870.1 |
CG32859-RA (eIF4E-7), mRNA |
0 |
0 |
0 |
4 |
4 |
NM_079692.2 |
CG4204-RA (Elongin-B), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_165128.1 |
CG3903-RD, transcript variant D (Gli), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_165127.1 |
CG3903-RC, transcript variant C (Gli), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_057254.3 |
CG3903-RA, transcript variant A (Gli), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_165129.1 |
CG3903-RE, transcript variant E (Gli), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_132793.2 |
CG9164-RA, transcript variant A (CG9164), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_142082.2 |
CG14356-RA (CG14356), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_170048.1 |
CG6726-RB, transcript variant B (CG6726), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_142863.1 |
CG6726-RA, transcript variant A (CG6726), mRNA |
0 |
0 |
0 |
3 |
8 |
NM_079470.2 |
CG10564-RA (Ac78C), mRNA |
0 |
0 |
0 |
3 |
8 |
NM_168199.1 |
CG8606-RB, transcript variant B (RhoGEF4), mRNA |
0 |
0 |
0 |
3 |
8 |
NM_141173.1 |
CG11133-RA (CG11133), mRNA |
0 |
0 |
0 |
3 |
7 |
NM_057490.3 |
CG6702-RA (Cbp53E), mRNA |
|
|
|